Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease
暂无分享,去创建一个
Osamu Abe | Masaaki Hori | Nobutaka Hattori | Koji Kamagata | Michimasa Suzuki | Shigeki Aoki | Kouhei Kamiya | Kanako K. Kumamaru | Yumiko Motoi | O. Abe | S. Aoki | K. Kumamaru | N. Hattori | K. Kamiya | M. Hori | K. Kamagata | T. Hatano | Michimasa Suzuki | K. Shimoji | A. Okuzumi | Y. Motoi | Keigo Shimoji | Taku Hatano | Ayami Okuzumi
[1] Dorothee P. Auer,et al. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis☆ , 2013, NeuroImage: Clinical.
[2] J. Helpern,et al. Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imaging , 2005, Magnetic resonance in medicine.
[3] Nin Bajaj,et al. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[4] Paul M. Matthews,et al. Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease , 2010, NeuroImage.
[5] J. Seibyl,et al. The molecular basis of dopaminergic brain imaging in Parkinson's disease. , 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[6] P. Svenningsson,et al. MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra. , 2012, Journal of Parkinson's disease.
[7] Y Nakata,et al. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[8] P. Basser,et al. Toward a quantitative assessment of diffusion anisotropy , 1996, Magnetic resonance in medicine.
[9] D R Rajput,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[10] C. Scherfler,et al. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease , 2011, Journal of Neurology.
[11] Martin Styner,et al. Imaging nigral pathology and clinical progression in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[12] Wang Zhan,et al. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging , 2012, Movement disorders : official journal of the Movement Disorder Society.
[13] Y. Sitoh,et al. Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease. , 2012, Parkinsonism & related disorders.
[14] Paul M. Matthews,et al. MRI characteristics of the substantia nigra in Parkinson's disease: A combined quantitative T1 and DTI study , 2009, NeuroImage.
[15] P. Boesiger,et al. Reduced field‐of‐view MRI using outer volume suppression for spinal cord diffusion imaging , 2007, Magnetic resonance in medicine.
[16] Patrice Péran,et al. Voxel‐based analysis of R2* maps in the healthy human brain , 2007, Journal of magnetic resonance imaging : JMRI.
[17] A. Lozano,et al. THE DOPAMINERGIC NIGROSTRIATAL SYSTEMAND PARKINSON'S DISEASE: MOLECULAR EVENTSIN DEVELOPMENT, DISEASE, AND CELL DEATH, AND NEW THERAPEUTIC STRATEGIES , 2007, Neurosurgery.
[18] A. Deutch,et al. Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.
[19] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[20] A. Albanese,et al. White Matter Involvement in Idiopathic Parkinson Disease: A Diffusion Tensor Imaging Study , 2009, American Journal of Neuroradiology.
[21] Guy B. Williams,et al. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. , 2010, Brain : a journal of neurology.
[22] W. Oertel,et al. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography , 1997, European Journal of Nuclear Medicine.
[23] Daniel C. Alexander,et al. NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain , 2012, NeuroImage.
[24] A. Leemans,et al. Characterizing the microstructural basis of “unidentified bright objects” in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis , 2014, NeuroImage: Clinical.
[25] T. Montine,et al. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease , 2005, Neurology.
[26] Yi-Hsin Weng,et al. Parkinson disease: diagnostic utility of diffusion kurtosis imaging. , 2011, Radiology.
[27] W. Schulz-Schaeffer. The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia , 2010, Acta Neuropathologica.
[28] H. Gertz,et al. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study. , 1991, Histology and histopathology.
[29] A. Stefani,et al. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. , 2010, Brain : a journal of neurology.
[30] C Trenkwalder,et al. Differentiation of Typical and Atypical Parkinson Syndromes by Quantitative MR Imaging , 2011, American Journal of Neuroradiology.
[31] Michael Brady,et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.
[32] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[33] Martin Styner,et al. Combined R2* and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[34] S Fook-Chong,et al. Case control study of diffusion tensor imaging in Parkinson’s disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[35] P. Basser,et al. Estimation of the effective self-diffusion tensor from the NMR spin echo. , 1994, Journal of magnetic resonance. Series B.
[36] S. Glantz,et al. Primer of Applied Regression & Analysis of Variance , 1990 .
[37] Haruyasu Yamada,et al. Normal aging in the central nervous system: quantitative MR diffusion-tensor analysis , 2002, Neurobiology of Aging.
[38] M. B. Spraker,et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease , 2009, Neurology.
[39] Hui Zhang,et al. Advanced diffusion imaging sequences could aid assessing patients with focal cortical dysplasia and epilepsy☆ , 2014, Epilepsy Research.
[40] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.